Back to search

Article

B and T cell responses to pre-erythrocytic R21/Matrix-M and blood-stage RH5.1/Matrix-M malaria vaccines in endemic settings

2025-11-13

Abstract excerpt

There is great interest in combining the licensed pre-erythrocytic malaria vaccine R21/Matrix-M ® and the blood-stage candidate vaccine RH5.1/Matrix-M ® to maximise efficacy against Plasmodium falciparum malaria. As protection is understood to be antibody-mediated for both vaccines, the success of a multi-stage vaccination strategy will be aided by understanding factors that impact the cellular drivers of humor...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
01a9ee5b-ddc0-572f-b5c6-68d175fe9554
DOI
10.1101/2025.11.11.25339978
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
B and T cell responses to pre-erythrocytic R21/Matrix-M and blood-stage RH5.1/Matrix-M malaria vaccines in endemic settingsDOI 10.1101/2025.11.11.25339978
Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled phase 2b trial in childrenSemantic proximity
Current Developments in Malaria Vaccination: A Concise Review on Implementation, Challenges, and Future DirectionsSemantic proximity
Superior antibody immunogenicity of a RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adultsSemantic proximity
Delayed booster dosing improves human antigen-specific Ig and B cell responses to the RH5.1/AS01<sub>B</sub> malaria vaccineSemantic proximity
Extended safety, immunogenicity and efficacy of a blood-stage malaria vaccine in malian children: 24-month follow-up of a randomized, double-blinded phase 2 trial.Semantic proximity
Multifunctional IgG/IgM antibodies and cellular cytotoxicity are elicited by the full-length MSP1 SumayaVac-1 malaria vaccineSemantic proximity
Towards a multi-antigen multi-stage malaria vaccineSemantic proximity
Repertoire, function, and structure of serological antibodies induced by the R21/Matrix-M malaria vaccineSemantic proximity
Protein/AS01B vaccination elicits stronger, more Th2-skewed antigen-specific human T follicular helper cell responses than heterologous viral vectorsSemantic proximity
Distinct immune responses associated with vaccination status and protection outcomes after malaria challengeSemantic proximity
A comparative analysis of memory B cell and antibody responses against <i>Plasmodium falciparum</i> merozoite surface protein 1 in children and adults from UgandaSemantic proximity
Longitudinal IgG antibody responses to <i>Plasmodium vivax</i> blood-stage antigens during and after acute vivax malaria in individuals living in the Brazilian AmazonSemantic proximity
Select a neighboring publication to make it the new centre.